Detalles de la búsqueda
1.
EGFR mutations in patients with non small-cell lung cancer in Bulgaria and treatment with gefitinib.
J BUON
; 20(1): 136-41, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25778308
2.
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Clin Cancer Res
; 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38771739
3.
A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer.
Oncotarget
; 11(33): 3105-3117, 2020 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32913555
4.
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.
Biosci Trends
; 14(1): 48-55, 2020 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32023563
5.
Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).
J Clin Oncol
; 30(29): 3596-603, 2012 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22965965
Resultados
1 -
5
de 5
1
Próxima >
>>